Gonadimmune Uses, Dosage, Side Effects and more
The Gonadimmune consists of synthetic peptides (constructed to "look like" GnRH), which are bound chemically to a carrier and suspended in a proprietary "delivery vehicle". The pharmaccine is administered intramuscularly to the patient by injection and induces an immune response or production of antibodies in the patient, which neutralize GnRH thus removing it from circulation.
| Trade Name | Gonadimmune |
| Generic | GnRH pharmaccine |
| Type | |
| Formula | C60H73N15O13 |
| Weight | 1212.3143 Da |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | January 7, 2025 at 1:49 am |
Uses
Investigated for use/treatment in prostate cancer.
How Gonadimmune works
The immunological neutralization of Gonadotropin Releasing Hormone (GnRH) by the antibodies induced by Gonadimmune shuts down the production of testosterone in the testes. Testosterone fuels prostate cancer, both early stage, primary cancer and metastatic (spreading) cancer. Like physical castration, hormonal, or biological blockage of testosterone has been shown to be efficacious in humans for the treatment of both early and late state prostate cancer. Aphton's Gonadimmune, which is expected to be reversible based on the mechanism of action (in contrast to surgical castration), induces hormonal, or biological blockage of testosterone.
